Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger)

Bullboard Posts

Post by bitcoinruson Mar 21, 2018 5:20pm

200 Views

Post# 27756847

25% drop on very heavy volume

Yeah,great time to buy. I warned you morons about James West.

IKN: The ballad of Seafield Resources (SFF.v)

incakolanews.blogspot.com/2012/11/the-ballad-of-seafield-resources-sffv.html

Nov 7, 2012 - Said Park decided to run a bullshit pump and dump using SFF by drilling a hole specifically to con the naive in the market at the same time as hiring an unethical bullshit pumper by the name of James West to promo his gig. Go here for the story, documented on several posts including the insider sales, the ...

Bullboard Posts

Morning Market Outlook for Oct. 3, 2024